Clinical diversity of sickle cell anemia: Genetic and cellular modulation of disease severity
- 1 June 1983
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 14 (4) , 405-416
Abstract
There is a great diversity in the clinical manifestations of sickle cell anemia. Some patients have severe repetitive infarctive episodes culminating in organ failure. Others have minor and nonincapacitating problems. This review focuses on the cellular and genetic factors that may play a role in modulating the clinical effects of the sickle hemoglobin gene. Understanding the role of putative modulators of disease severity may in the future allow the introduction of novel methods of therapy.Keywords
This publication has 70 references indexed in Scilit:
- The Interaction of Alpha-Thalassemia and Homozygous Sickle-Cell DiseaseNew England Journal of Medicine, 1982
- Concurrent Sickle-Cell Anemia and α-ThalassemiaNew England Journal of Medicine, 1982
- Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhoodThe Journal of Pediatrics, 1981
- Erythrocyte Adherence to Endothelium in Sickle-Cell AnemiaNew England Journal of Medicine, 1980
- Individual Variation in the Production and Survival of F Cells in Sickle-Cell DiseaseNew England Journal of Medicine, 1978
- Sickle-Cell Anemia: Molecular and Cellular Bases of Therapeutic ApproachesNew England Journal of Medicine, 1978
- Sickle cell syndromesThe Journal of Pediatrics, 1978
- The rates of polymerization and depolymerization of sickle cell hemoglobinBiochemical and Biophysical Research Communications, 1974
- A temperature-dependent latent-period in the aggregation of sickle-cell deoxyhemoglobinBiochemical and Biophysical Research Communications, 1974
- The Inheritance of Sickle Cell AnemiaScience, 1949